Le Gao

Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Erratum: Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Erratum: Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Journal: iScience

Published: March 19, 2026

Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.

Journal: iScience

Published: February 14, 2024

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.

Journal: Frontiers in immunology

Published: May 24, 2022

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer.

Hsa_Circ_0066351 Acts as a Prognostic and Immunotherapeutic Biomarker in Colorectal Cancer.

Journal: Frontiers in immunology

Published: April 25, 2022

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.

Journal: iScience

Published: February 25, 2022

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.

Journal: EBioMedicine

Published: September 28, 2021

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 12, 2021

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.

tRF3008A suppresses the progression and metastasis of colorectal cancer by destabilizing FOXK1 in an AGO-dependent manner.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 05, 2021

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.

Journal: Aging

Published: July 27, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026